Cargando…
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
With randomised trial data confirming that continuous glucose monitoring (CGM) is associated with improvements in maternal glucose control and neonatal health outcomes, CGM is increasingly used in antenatal care. Across pregnancy, the ambition is to increase the CGM time in range (TIR), while reduci...
Autor principal: | Murphy, Helen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560014/ https://www.ncbi.nlm.nih.gov/pubmed/31161344 http://dx.doi.org/10.1007/s00125-019-4904-3 |
Ejemplares similares
-
Continuous Glucose Monitoring in Pregnancy: We Have the Technology but Not All the Answers
por: Murphy, Helen R.
Publicado: (2013) -
Benefits of Real-Time Continuous Glucose Monitoring in Pregnancy
por: Yamamoto, Jennifer M., et al.
Publicado: (2021) -
Effect of real‐time continuous glucose monitoring on hypoglycemia in adult type 1 diabetes patients
por: Jia, Weiping
Publicado: (2017) -
Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
por: Yang, Junpeng, et al.
Publicado: (2020) -
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
por: Battelino, Tadej, et al.
Publicado: (2019)